ASS1 and cancer: Metastatic renal cancer cells reactivate ASS1, an enzyme suppressed in primary ccRCC, in order to maintain the invasive potential of metastatic renal cancer cells in vitro and in vivo and to modulate the sensitivity of metastatic cancer cells to arginine depletion [1].